Trial to use stem cells to treat infant heart defects

The Mayo Clinic has received federal approval for a trial that will use stem cells from babies' own umbilical cords to treat heart defects such as hypoplastic left heart syndrome. The trial, considered the first of its kind, will commence upon enrollment of 10 eligible patients.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.) · KTTC-TV (Rochester, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ